Oncology Events Calendar
Discover conferences, symposia and other events worldwide.
View monthly calendar
Submit your event
233 event(s) found
ESTRO 2026
ESTRO 2026 will take place in Stockholm, Sweden from 15 to 19 May and introduce this year’s congress theme: “Innovating Radiation Oncology, Together”. ESTRO 2025 focused on transformative innovation through partnership, via collaboration within our Radiation Oncology Community and especially with our scientific friends and partners from basic science, translational research and multidisciplinary cancer care. This journey will be continued, aiming to stay at the forefront of innovation. ESTRO 2026 will broach the opportunities to innovate our discipline itself, to optimally prepare us for tomorrow’s clinical, professional and scientific changes and challenges. The theme will be reflected throughout the programme. Exciting keynote speakers will surprise us, more patients than ever will provide their perspectives and reflections, and interaction between chairs, speakers and the participants will be further increased, to maximise the learning experience. The joint call for abstracts with the Lancet Oncology will be continued. We will acknowledge scientific excellence, not only by awarding a select few individuals but also the TOP 5% of all abstracts. Our communication of breakthrough science via social channels and the press will be boosted, both during and after the congress. These measures will make ESTRO 2026 THE meeting to showcase and learn from TOP practice-changing clinical trials and breakthrough research in all fields of Radiation Oncology. ESTRO 2026 will be in vibrant Stockholm for the first time, an exciting Scandinavian city which is not only the capital of Sweden, but the home of many Radiation Oncology companies. Stockholm is famous for its sustainability and its Scandinavian efficiency. Stockholm will host the beloved ESTRO 5K run, and our famous Monday night ESTRO party! ESTRO 2026 will host Europe’s largest industry exhibition in Radiation Oncology, offering you a unique opportunity to interact with industry leaders and to find out about their latest innovations. Join the ever-growing ESTRO family in Stockholm.
14/05/2026 - 18/05/2026
In-person
ESTRO
Stockholm, Sweden
Stockholmsmässan
Cancer Research into Action
To close its wonderful 60th anniversary year, IARC will offer you the opportunity to register for a major scientific conference that will take place over three days, from 19 to 21 May 2026. This conference will bring together experts from around the world and will be held at IARC and la Halle Tony Garnier.
18/05/2026 - 20/05/2026 In-person IARC Lyon, France 1. Halle Tony Garnier 2. IARC premises Soirée régionale Cas Cliniques maladies rares immuno-hématologiques « PACA-Corse »
In French: "Les centres de référence et de compétence maladies rares de la région vous invite à assister à une soirée de cas cliniques, présentés par les internes de leur service. Un vote sera fait en fin de soirée et l’interne du meilleur cas clinique gagnera une prise en charge au congrès européen de son choix. Inscription : gratuite mais obligatoire, uniquement pour les médecins et internes de la région PACA Corse, en complétant le formulaire ci-dessous. Déplacements (train et hôtel si besoin) pris en charge directement par la filière MaRIH sur demande via le formulaire (pas de remboursements possibles)."
19/05/2026 - 19/05/2026 In-person MaRIH, Filières de Santé Maladies Rares Nice, France Holiday Inn 6th SUNRiSE Meeting
6th SUNRiSE Meeting organized by SUNRiSE Network
26/05/2026 - 28/05/2026 In-person SUNRiSE Network Bordeaux, France TBD Clinical Ethics: End-of-Life Care
Clinical Ethics: End-of-Life Care organized by Deakin Bioethics (Deakin University)
28/05/2026 - 28/05/2026 In-person Deakin Bioethics (Deakin University) Melbourne, VIC, Australia TBD
ASCO® Annual Meeting 2026
The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger. This is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
28/05/2026 - 01/06/2026 Hybrid ASCO Chicago, IL, United States McCormick Place 54 reunión anual PETHEMA
Latest edition of PETHEMA's annual meeting, held in Spanish. More information coming soon…
28/05/2026 - 28/05/2026 In-person PETHEMA To be announced…, Spain To be announced…
SIFEM 2026 - Osons repenser les dogmes
In French: "Ce congrès sera l’occasion de revisiter les dogmes en imagerie du sein et du pelvis, de confronter les idées reçues aux données les plus récentes, et de proposer des alternatives éclairées aux paradigmes établis." Nous aborderons des sujets très pratiques, partagerons nos difficultés et discuterons ensemble des pièges rencontrés au quotidien dans notre pratique de l’imagerie de la femme, qu’il s’agisse de la pertinence des examens, de l’intégration de l’intelligence artificielle ou d’une meilleure anticipation des défis cliniques, technologiques et organisationnels auxquels nous faisons face chaque jour."
04/06/2026 - 04/06/2026 In-person SIFEM Montpellier, France Corum
EACR 2026 Congress
The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
07/06/2026 - 10/06/2026 In-person EACR Budapest, Hungary HungexpoSymposium iTOX 2026
In French: "Le symposium ITOX 2026 réunit des experts nationaux et internationaux pour aborder les toxicités liées aux immunothérapies en cancérologie, avec un focus particulier sur les effets indésirables des inhibiteurs de points de contrôle immunitaires et des thérapies cellulaires (CAR-T, T-cell engagers). Le programme comprend : - Sessions éducatives en français : "Nouvelles" immunothérapies antitumorales Toxiciés des ADC / immunoconjugués cytotoxiques Evolution des prises en charges Pièges diagnostiques - Discussion de cas cliniques complexes Points de vue des patient.es sur les effets indésirables immuno-médiés - Sessions orales en anglais : Cellular therapies Keynote lecture Dissecting the mechanism of … Immunosuppressive drugs Cet événement est un lieu privilégié d’échanges interdisciplinaires entre oncologues, immunologistes, internistes, chercheurs et cliniciens impliqués dans la prise en charge des patients traités par immunothérapies."
08/06/2026 - 09/06/2026 In-person Gustave Roussy Le Kremlin-Bicêtre (Paris), France Faculté de médecine, Université Paris-Saclay
EHA2026 Congress
EHA2026 will once again offer an exceptional scientific program, featuring a seamless flow of engagement across Plenary Sessions—including the Opening Ceremony, Plenary Abstracts Session, and Presidential Sessions—alongside carefully curated Sponsor Symposiums spread throughout each Congress day.
10/06/2026 - 13/06/2026 In-person EHA Stockholm, Sweden Stockholmsmässan
SFCO : Congrès 2026
In French: "Face aux mutations rapides de notre environnement – innovations technologiques, évolutions thérapeutiques, attentes accrues en termes de qualité et de personnalisation des soins – la chirurgie oncologique se trouve à un tournant. Ce congrès se veut le lieu de la réflexion collective, de l’audace scientifique et du partage d’expertise. Durant ces deux journées, nous aurons l’occasion d’explorer les enjeux majeurs à venir : progrès technologiques, prise en charge multidisciplinaire, adaptation des pratiques aux nouvelles réalités, et maintien de l’excellence chirurgicale pour servir au mieux nos patients."
11/06/2026 - 12/06/2026 In-person SFCO Lyon, France L’Embarcadère
6ème Journée de l’innovation en cancérologie pulmonaire
In French: "La journée consacrée aux Innovations dans le traitement du Cancer Pulmonaire est de retour."
12/06/2026 - 12/06/2026 In-person Hôpital Cochin, AP-HP, Université Paris Cité, CARPEM Paris, France Hôpital Cochin EORTC-ESMO-AACR Methods in Clinical Cancer Research Workshop
The annual Methods in Clinical Cancer Research Workshop (MCCR) is a week-long course designed to educate and train early-career investigators in the best practices of clinical trial design and provide access to experienced clinical investigators from different institutions and countries with expertise across all areas of clinical research.
13/06/2026 - 18/06/2026 In-person EORTC, ESMO, AACR Sint-Michielsgestel, Netherlands Hotel de l’Europe.png?width=800&height=156&name=Drug%20Discovery%20Europe%202026%20(Light).png)
Drug Discovery Europe - Part of Discovery & Development Europe 2026
Join world-leading experts at our annual Drug Discovery, Neuroscience Drug Development, and Automation & AI & Data programmes—showcasing bold strategies, breakthrough science, and cutting-edge technologies in target discovery, medicinal chemistry, and drug design. Gain fresh insights from case studies on PROTACs, ADCs, molecular glues, and the power of AI-driven tools in early R&D. Discover advances in tackling neuroscience and age-related diseases, strategies to cross the blood–brain barrier, and the data-driven digital tech transforming discovery workflows.
15/06/2026 - 15/06/2026 In-person Oxford Global Berlin, Germany Estrel Congress Centre Target Innovation & Novel Screening Technologies
We’re partnering with Oxford Global to host an ELRIG scientific track as part of their Drug Discovery Europe 2026 conference.
15/06/2026 - 15/06/2026 In-person ELRIG, Oxford Global Berlin, Germany Estrel Congress Centre
Drug Discovery USA 2026: Emerging multifunctional small molecule and biologic approaches to drug difficult targets
Recent advances in chemical biology and protein engineering are expanding the boundaries of which proteins can be modulated pharmacologically. Multifunctional small molecules (such as molecular glues, targeted protein degraders, and allosteric modulators) are enabling precise control over protein stability, localization and activity, often by exploiting endogenous cellular pathways. In parallel, novel biologic modalities, including engineered antibodies, multi-specific binders, peptide scaffolds, nucleotide and RNA therapeutics, offer complementary strategies to engage complex or transient target surfaces with high affinity and specificity. Collectively, these approaches are reshaping early‑stage drug discovery by providing versatile platforms to modulate challenging targets through mechanisms beyond simple inhibition. Furthermore, hybrid strategies that integrate small molecules with biologics, such as antibody–drug conjugates (ADCs) and chemically enhanced biologics, are demonstrating synergistic potential. Together, these emerging technologies highlight a rapidly evolving therapeutic landscape in which difficult to drug targets are increasingly accessible, opening new avenues for disease intervention and precision medicine. Continued innovation in molecular design, delivery, and mechanistic understanding will be critical to fully realize the promise of these next‑generation modalities.
16/06/2026 - 17/06/2026 In-person ELRIG Boston, MA, USA Pfizer (Research & Manufacturing site) 21ème Journées GSF-GETO
21ème Journées GSF-GETO organized by GSF
17/06/2026 - 19/06/2026 In-person GSF Reims, France TBD Cell Symposia: Multifaceted mitochondria
Cell Symposia: Multifaceted mitochondria organized by Cell (Elsevier Ltd.)
21/06/2026 - 23/06/2026 In-person Cell (Elsevier Ltd.) Glasgow, Scotland, United Kingdom TBD Prague Metabolism and Signaling Symposium
Prague Metabolism and Signaling Symposium organized by Prague Metabolism Symposium
24/06/2026 - 27/06/2026 In-person Prague Metabolism Symposium Prague, Czech Republic TBD
MASCC/ISOO 2026 Annual Meeting
The MASCC/ISOO Annual Meeting is the leading international, interdisciplinary event dedicated to supportive cancer care. Our 2026 theme—Coordinated and Individualized Supportive Cancer Care—reflects our commitment to advancing care that is both evidence-based and patient-centered. Jo Bowen This year’s program will spotlight three key areas: “Mind the Gap”: Maximizing Access to Supportive Care for All Addressing disparities in supportive care for underserved communities, including those in rural and remote areas; gender and sexually diverse populations; culturally and linguistically diverse groups; older adults; individuals of lower socioeconomic status; those in low- and middle-income countries; and First Nations Peoples. Lifestyle and Behavioral Support in Cancer Care Exploring the role of exercise, nutrition, integrative medicine, psychotherapy, and digital health technologies in enhancing care during and after treatment. Optimizing Toxicity Management of Novel Therapies Focusing on the prediction, assessment, and management of toxicities associated with emerging cancer treatments. In addition to these focus areas, the program will feature a broad range of sessions led by MASCC/ISOO study groups, covering topics that address the full spectrum of challenges faced by patients during and after treatment. The meeting offers excellent opportunities for networking, collaboration, and the chance to present your own research to a global audience. Social events will showcase Melbourne’s vibrant food, arts, and sports scenes—making the meeting both enriching and memorable.
24/06/2026 - 26/06/2026 In-person MASCC, ISOO Melbourne, Australia TBD Advances in Malignant Lymphoma: From Discovery to Clinical Impact
The fifth Advances in Malignant Lymphoma: From Discovery to Clinical Impact conference, held in cooperation with the International Conference on Malignant Lymphoma (ICML), will convene experts from academia, industry, government, and foundations to examine how molecular mechanisms and translational research are driving therapeutic progress. The program will highlight advances in understanding germinal center biology and beyond, lymphoma origins and classifications, including rare and aggressive subtypes, and microenvironmental influences, that define disease behavior and therapeutic response. This conference is uniquely positioned to integrate scientific discoveries across epigenetics, disease modeling, and computational biology with emerging therapeutic advances in antibody evolution, next-generation clinical assessment, degraders, and cellular therapies. Together, these efforts will capture the entire spectrum of lymphoma research and drive progress toward improved patient outcomes.
24/06/2026 - 27/06/2026 In-person AACR Philadelphia, PA, United States Philadelphia Convention Center ASCO Breakthrough 2026
ASCO Breakthrough 2026 organized by ASCO
25/06/2026 - 27/06/2026 Hybrid ASCO Singapore, Singapore TBD ANZUP ASM 2026
ANZUP ASM 2026 organized by ANZUP
28/06/2026 - 30/06/2026 In-person ANZUP Adelaide, SA, Australia TBD